Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels |
---|---|---|---|
1 | |||
Coagulopathy | postmarketing | x | |
Thrombocytopenia | postmarketing | x | |
Prothrombin level increased | postmarketing | x | |
Shutdown renal | postmarketing | x | |
Activated partial thromboplastin time prolonged | postmarketing | x | |
Serum ferritin increased | postmarketing | x | |
Iron overload | postmarketing | x | |
Body temperature increased | x | ||
Leukocytosis | x | ||
Phlebitis | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |